Physician profile
Daniel Keating
NPI 1639192156
$11,784.63
in general payments reported to CMS, 2019-2025
40 companies · $1,812 in 2025
The $1,812 reported for 2025 was more than what 89% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $975 · 2020: $796 · 2021: $1,124 · 2022: $2,548 · 2023: $2,565 · 2024: $1,964 · 2025: $1,812.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,340.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prodigy Surgical Distribution, INC. | $1,200.00 | 2022 | |
| Integra Lifesciences Corporation | $855.53 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Treace Medical Concepts, INC. | $847.01 | 2021-2025 | |
| Abbott Laboratories | $642.48 | 2019-2025 | Proclaim, Octrode, Eterna |
| Horizon Therapeutics Plc | $601.69 | 2019-2023 | Krystexxa |
| Next Science LLC | $597.64 | 2023-2024 | Xperience, Surgx, Blastx |
| Smith+Nephew, INC. | $588.42 | 2019-2024 | Memofix Super Elastic Nitinol Staple System |
| Organogenesis INC. | $524.81 | 2019-2024 | |
| Paratek Pharmaceuticals, INC. | $503.27 | 2020-2024 | Nuzyra |
| Stryker Corporation | $488.32 | 2019-2025 | Iconix, Insignia, Mako |
| Amgen INC. | $439.06 | 2024-2025 | Krystexxa |
| Medtronic, INC. | $414.20 | 2023-2025 | Endurant Iis, Inceptiv, Hawkone |
| Advanced Oxygen Therapy INC. | $361.56 | 2019-2022 | |
| Orthofix Medical, INC. | $315.70 | 2020-2023 | Physio-Stim |
| Kci USA, INC. | $275.74 | 2019-2023 | Abthera, Prevena, V.A.C. Dermatac |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $257.42 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Sanara Medtech INC. | $219.04 | 2024-2025 | Celleraterx, Celleraterx |
| Kerecis Limited | $205.93 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Zimmer Biomet Holdings, INC. | $204.76 | 2024-2025 | Tapestry |
| Solventum Corporation | $194.64 | 2024-2025 | V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta, Prevena |
| Averitas Pharma INC. | $188.08 | 2023-2025 | Qutenza |
| Triad Life Sciences INC. | $177.96 | 2022 | |
| Medline Industries Lp | $162.96 | 2024 | |
| Lifenet Health | $159.60 | 2025 | Theragenesis Wound Matrix, Optium (Tgel & Tput) |
| Musculoskeletal Transplant Foundation INC. | $151.03 | 2023 | |
| Acera Surgical, INC. | $149.03 | 2023 | Restrata Wound Matrix |
| Nevro Corp. | $144.43 | 2023 | Senza |
| Heron Therapeutics, INC. | $132.00 | 2022 | |
| Innovation Technologies INC | $124.99 | 2023 | Irrisept |
| Misonix INC | $124.00 | 2021 | |
| Abbvie INC. | $110.60 | 2022 | |
| Biopoly LLC | $105.00 | 2024 | |
| Melinta Therapeutics, LLC | $97.96 | 2021 | |
| Boston Scientific Corporation | $95.31 | 2021 | |
| Ossio INC | $24.21 | 2022 | |
| Davol INC. | $23.43 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $22.84 | 2023 | Seglentis |
| Takeda Pharmaceuticals U.S.A., INC. | $21.75 | 2020 | |
| Grt US Holding, INC. | $19.07 | 2022 | |
| Merck Sharp & Dohme LLC | $13.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Keating listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.